Sébastien Moreno

Title: The Innovative Contributions of Sébastien Moreno

Introduction

Sébastien Moreno is a notable inventor based in Vence, France. He has made significant contributions to the field of biomedical research, particularly in the area of depression treatment. His work has led to the development of innovative peptides that hold promise for therapeutic applications.

Latest Patents

Moreno holds a patent for "Peptides derived from the propeptide NTSR3 and their use in the treatment of depression." This patent discloses new peptides derived from the neurotensin receptor 3 (NTSR3) and outlines their potential use in treating various diseases, especially depression. This innovative approach could pave the way for new treatment options for individuals suffering from this condition.

Career Highlights

Throughout his career, Sébastien Moreno has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université de Nice-Sophia Antipolis. His research has focused on the intersection of neurobiology and therapeutic development, contributing to advancements in understanding and treating mental health disorders.

Collaborations

Moreno has collaborated with esteemed colleagues, including Jean Mazella and Marc Borsotto. These partnerships have enhanced his research efforts and facilitated the exploration of new therapeutic avenues.

Conclusion

Sébastien Moreno's innovative work in developing peptides for depression treatment exemplifies the impact of research on mental health. His contributions continue to inspire advancements in biomedical science and offer hope for improved therapeutic strategies.